In vitro approaches to the identification and characterization of skin sensitizers

Expert Review of Dermatology

Volumn 8, Issue 4, 2013, Pages 395-405

  Vocanson, Marc ^a,b,c,d   Nicolas, Jean Francois ^a,b,c,d,e   Basketter, David ^f  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LYON   (France)

^d CNRS   (France)

^e Allergology and Clinical Immunology   (France)

^f DABMEB CONSULTANCY LTD   (United Kingdom)

Author keywords

hazard identification; in vitro alternatives; risk assessment; skin allergy; skin sensitization

Indexed keywords

EID: 84883083481     PISSN: 17469872     EISSN: 17469880     Source Type: Journal    
DOI: 10.1586/17469872.2013.814882     Document Type: Review

References (124)

1. Basketter D, Maxwell G. Identification and characterization of allergens: In vitro alternatives. Expert Rev. Dermatol. 2(4), 471-480 (2007
2. Martin SF. Contact dermatitis: From pathomechanisms to immunotoxicology. Exp. Dermatol. 21(5), 382-389 (2012
3. Rustemeyer T, Hoogstraten IW, Blomberg BM, Gibbs S, Scheper R. Mechanisms of irritant and allergic contact dermatitis. In: Contact Dermatitis. Johansen JD, Frosch PJ, Lepoittevin J-P (Eds). Springer, Berlin/ Heidelberg, Germany, 43-90 (2011
4. Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64(12), 1699-1714 (2009
5. Dupuis G, Benezra C. Allergic Contact Dermatitis to Simple Chemicals: A Molecular Approach. Marcel Dekker, NY, USA (1982
6. Lepoittevin JP. Allergic Contact Dermatitis: The Molecular Basis. Springer, Berlin/ Heidelberg, Germany (1998
7. Karlberg AT, Basketter D, Goossens A, Lepoittevin JP. Regulatory classification of substances oxidized to skin sensitizers on exposure to air. Contact Dermatitis 40(4), 183-188 (1999
8. Matura M, Skold M, Borje A et al. Selected oxidized fragrance terpenes are common contact allergens. Contact Dermatitis 52(6), 320-328 (2005
9. Elahi EN, Wright Z, Hinselwood D, Hotchkiss SA, Basketter DA, Pease CK. Protein binding and metabolism influence the relative skin sensitization potential of cinnamic compounds. Chem. Res. Toxicol. 17(3), 301-310 (2004
10. Smith Pease CK, Basketter DA, Patlewicz GY. Contact allergy: The role of skin chemistry and metabolism. Clin. Exp. Dermatol. 28(2), 177-183 (2003
11. Smith CK, Cheung C, Elahi EN, Hotchkiss SA. High-performance liquid chromatography method for the quantification of non-radiolabelled cinnamic compounds in analytes derived from human skin absorption and metabolism experiments. J. Chromatogr. B Biomed. Sci. Appl. 758(2), 249-264 (2001
12. Gotz C, Pfeiffer R, Tigges J et al. Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: Activating enzymes (Phase I). Exp. Dermatol. 21(5), 358-363
13. Gotz C, Pfeiffer R, Tigges J et al. Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: Phase II enzymes. Exp. Dermatol. 21(5), 364-369
14. Divkovic M, Pease CK, Gerberick GF, Basketter DA. Hapten-protein binding: From theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 53(4), 189-200 (2005
15. Karlberg AT, Bergstrom MA, Borje A, Luthman K, Nilsson JL. Allergic contact dermatitis -formation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 21(1), 53-69 (2008
16. Ibrahim R, Kasting GB. Improved method for determining partition and diffusion coefficients in human dermis. J. Pharm. Sci. 99(12), 4928-4939 (2010
17. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci. 43(3), 159-169 (2006
18. Matzinger P. Friendly and dangerous signals: Is the tissue in control? Nat. Immunol. 8(1), 11-13 (2007
19. Martin SF, Esser PR, Weber FC et al. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66(9), 1152-1163 (2011
20. Van Och FM, Van Loveren H, Van Wolfswinkel JC, Machielsen AJ, Vandebriel RJ. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology 210(2-3), 95-109 (2005
21. Griffiths CE, Dearman RJ, Cumberbatch M, Kimber I. Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine 32(2), 67-70 (2005
22. Cumberbatch M, Clelland K, Dearman RJ, Kimber I. Impact of cutaneous IL-10 on resident epidermal Langerhans' cells and the development of polarized immune responses. J. Immunol. 175(1), 43-50 (2005
23. Welss T, Basketter DA, Schroder KR. In vitro skin irritation: Facts and future. State of the art review of mechanisms and models. Toxicol. In Vitro 18(3), 231-243 (2004
24. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: Mechanisms and clinical consequences. Nat. Rev. Immunol. 4(3), 211-222 (2004
25. Smith HR, Basketter DA, Mcfadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin. Exp. Dermatol. 27(2), 138-146 (2002
26. Steinhoff M, Brzoska T, Luger TA. Keratinocytes in epidermal immune responses. Curr. Opin. Allergy Clin. Immunol. 1(5), 469-476 (2001
27. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CE. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br. J. Dermatol. 142(3), 401-412 (2000
28. Gomez DE Aguero M, Vocanson M et al. Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J. Clin. Invest. 122(5), 1700-1711 (2012
29. Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36(5), 873-884 (2012
30. Steinman RM. Decisions about dendritic cells: Past, present, and future. Annu. Rev. Immunol. 30, 1-22 (2012
31. Toebak MJ, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T. Dendritic cells: Biology of the skin. Contact Dermatitis 60(1), 2-20 (2009
32. Klechevsky E, Morita R, Liu M et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29(3), 497-510 (2008
33. Kabashima K, Shiraishi N, Sugita K et al. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171(4), 1249-1257 (2007
34. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177, 134-140 (2000
35. Nakayamada S, Takahashi H, Kanno Y, O'shea JJ. Helper T cell diversity and plasticity. Curr. Opin. Immunol. 24(3), 297-302 (2012
36. Johansen JD, Frosch PJ, Lepoittevin JP. Contact Dermatitis. Springer, Berlin/Heidelberg, Germany (2010
37. Wilhelm KP, Zhai H, Maibach HI. Dermatotoxicology. Informa Healthcare, London, UK (2012
38. Frosch PJ, Menńé T, Lepoittevin JP. Contact Dermatitis. Springer, Berlin/Heidelberg, Germany (2006
39. Aptula AO, Patlewicz G, Roberts DW. Skin sensitization: Reaction mechanistic applicability domains for structure-activity relationships. Chem. Res. Toxicol. 18(9), 1420-1426 (2005
40. Roberts DW, Patlewicz G, Kern PS et al. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem. Res. Toxicol. 20(7), 1019-1030 (2007
41. Barratt MD, Langowski JJ. Validation and subsequent development of the DEREK skin sensitization rulebase by analysis of the BgVV list of contact allergens. J. Chem. Inf. Comput. Sci. 39(2), 294-298 (1999
42. Langton K, Patlewicz GY, Long A, Marchant CA, Basketter DA. Structure-activity relationships for skin sensitization: Recent improvements to Derek for Windows. Contact Dermatitis 55(6), 342-347 (2006
43. Patlewicz G, Aptula AO, Uriarte E et al. An evaluation of selected global (Q)SARs/ expert systems for the prediction of skin sensitisation potential. SAR QSAR Environ. Res. 18(5-6), 515-541 (2007
44. Jenkinson C, Jenkins RE, Aleksic M, Pirmohamed M, Naisbitt DJ, Park BK. Characterization of p-phenylenediaminealbumin binding sites and T-cell responses to hapten-modified protein. J. Invest. Dermatol. 130(3), 732-742 (2010
45. Roberts DW, Aptula AO, Patlewicz G. Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the schiff base applicability domain for skin sensitization. Chem. Res. Toxicol. 19(9), 1228-1233 (2006
46. Roberts DW, Basketter DA. Quantitative structure-activity relationships: Sulfonate esters in the local lymph node assay. Contact Dermatitis 42(3), 154-161 (2000
47. Roberts DW, Williams DL. The derivation of quantitative correlations between skin sensitisation and physio-chemical parameters for alkylating agents, and their application to experimental data for sultones. J. Theor. Biol. 99(4), 807-825 (1982
48. Aptula AO, Roberts DW. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: General principles and application to reactive toxicity. Chem. Res. Toxicol. 19(8), 1097-1105 (2006
49. Patlewicz GY, Basketter DA, Pease CK et al. Further evaluation of quantitative structure-activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens. Contact Dermatitis 50(2), 91-97 (2004
50. Aptula AO, Roberts DW, Pease CK. Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles. Contact Dermatitis 56(1), 54-56 (2007
51. Eilstein J, Gimenez-Arnau E, Duche D, Rousset F, Lepoittevin JP. Synthesis and reactivity toward nucleophilic amino acids of 2,5-[13C]-dimethyl- p-benzoquinonediimine. Chem. Res. Toxicol. 19(9), 1248-1256 (2006
52. Nohynek GJ, Duche D, Garrigues A, Meunier PA, Toutain H, Leclaire J. Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol. Lett. 158(3), 196-212 (2005
53. Smith C, Hotchkiss S. Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms. Taylor & Francis, Oxfordshire, UK (2001
54. Mekenyan O, Dimitrov S, Dimitrova N et al. Metabolic activation of chemicals: In-silico simulation. SAR QSAR Environ. Res. 17(1), 107-120 (2006
55. Gerberick GF, Vassallo JD, Foertsch LM, Price BB, Chaney JG, Lepoittevin JP. Quantification of chemical peptide reactivity for screening contact allergens: A classification tree model approach. Toxicol. Sci. 97(2), 417-427 (2007
56. Gerberick GF, Vassallo JD, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 81(2), 332-343 (2004
57. Basketter D, Angers-Loustau A, Casati S. ECVAM: Progressing skin sensitization alternatives for hazard identification. Contact Dermatitis 66(Suppl. 2), 24 (2012
58. Gerberick GF, Troutman JA, Foertsch LM et al. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol. Sci. 112(1), 164-174 (2009
59. Aleksic M, Pease CK, Basketter DA, Panico M, Morris HR, Dell A. Mass spectrometric identification of covalent adducts of the skin allergen 2,4-dinitro-1-chlorobenzene and model skin proteins. Toxicol. In Vitro 22(5), 1169-1176 (2008
60. Alvarez-Sanchez R, Divkovic M, Basketter D et al. Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2- methylisothiazol-3-one to human serum albumin: Identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry. Chem. Res Toxicol. 17(9), 1280-1288 (2004
61. Basketter D, Pease C, Kasting G et al. Skin sensitisation and epidermal disposition: The relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59. Altern. Lab. Anim. 35(1), 137-154 (2007
62. Ibrahim R, Nitsche JM, Kasting GB. Dermal clearance model for epidermal bioavailability calculations. J. Pharm. Sci. 101(6), 2094-2108 (2012
63. Kretsos K, Kasting GB, Nitsche JM. Distributed diffusion-clearance model for transient drug distribution within the skin. J. Pharm. Sci. 93(11), 2820-2835 (2004
64. Bergstrom MA, Ott H, Carlsson A et al. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. 127(5), 1145-1153 (2007
65. Chipinda I, Ruwona TB, Templeton SP, Siegel PD. Use of the human monocytic leukemia THP-1 cell line and co-incubation with microsomes to identify and differentiate hapten and prohapten sensitizers. Toxicology 280(3), 135-143 (2011
66. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Eur. J. Dermatol. 19(4), 325-332 (2009
67. Galbiati V, Mitjans M, Lucchi L et al. Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. Toxicol. In Vitro 25(3), 724-732 (2011
68. Teunis M, Corsini E, Smits M et al. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol. In Vitro 27(3), 1135-1150 (2012
69. Van Der Veen JW, Pronk TE, Van Loveren H, Ezendam J. Applicability of a keratinocyte gene signature to predict skin sensitizing potential. Toxicol. In Vitro 27(1), 314-322 (2012
70. Emter R, Ellis G, Natsch A. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharmacol. 245(3), 281-290 (2010
71. Natsch A, Gfeller H, Rothaupt M, Ellis G. Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. Toxicol. In Vitro 21(7), 1220-1226 (2007
72. Natsch A. The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers -functional relevance and a hypothesis on innate reactions to skin sensitizers. Toxicol Sci 113(2), 284-292 (2010
73. Reis E Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6(6), 476-483 (2006
74. Casati S, Aeby P, Basketter DA et al. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern. Lab. Anim. 33(1), 47-62 (2005
75. Ryan CA, Gerberick GF, Gildea LA et al. Interactions of contact allergens with dendritic cells: Opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol. Sci. 88(1), 4-11 (2005
76. Kaplan DH, Igyarto BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 12(2), 114-124 (2012
77. Reuter H, Spieker J, Gerlach S et al. In vitro detection of contact allergens: Development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells. Toxicol. In Vitro 25(1), 315-323 (2011
78. Migdal C, Tailhardat M, Courtellemont P, Haftek M, Serres M. Responsiveness of human monocyte-derived dendritic cells to thimerosal and mercury derivatives. Toxicol. Appl. Pharmacol. 246(1-2), 66-73 (2010
79. De Smedt AC, Van Den Heuvel RL, Van Tendeloo VF, Berneman ZN, Schoeters GE. Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants. Toxicol. Lett. 156(3), 377-389 (2005
80. Ryan CA, Gildea LA, Hulette BC, Dearman RJ, Kimber I, Gerberick GF. Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicol. Lett. 150(3), 301-316 (2004
81. Cumberbatch M, Dearman RJ, Griffiths CE, Kimber I. Epidermal Langerhans cell migration and sensitisation to chemical allergens. Apmis 111(7-8), 797-804 (2003
82. Guironnet G, Dalbiez-Gauthier C, Rousset F, Schmitt D, Peguet-Navarro J. In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. Toxicol. In Vitro 14(6), 517-522 (2000
83. Pichowski JS, Cumberbatch M, Dearman RJ, Basketter DA, Kimber I. Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: Inter-individual differences and relevance for sensitization testing. J. Appl. Toxicol. 21(2), 115-121 (2001
84. Dos Santos GG, Reinders J, Ouwehand K, Rustemeyer T, Scheper RJ, Gibbs S. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol. Appl. Pharmacol. 236(3), 372-382 (2009
85. Nukada Y, Ashikaga T, Miyazawa M et al. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency. Toxicol. In Vitro 26(7), 1150-1160 (2012
86. Takahashi T, Kimura Y, Saito R et al. An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8. Toxicol. Sci. 124(2), 359-369 (2011
87. Del Bufalo A, Bernad J, Dardenne C et al. Contact sensitizers modulate the arachidonic acid metabolism of PMAdifferentiated U-937 monocytic cells activated by LPS. Toxicol. Appl. Pharmacol. 256(1), 35-43 (2011
88. Python F, Goebel C, Aeby P. Comparative DNA microarray analysis of human monocyte derived dendritic cells and MUTZ-3 cells exposed to the moderate skin sensitizer cinnamaldehyde. Toxicol. Appl. Pharmacol. 239(3), 273-283 (2009
89. Hulette BA, Ryan CA, Gerberick GF. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol. Appl. Pharmacol. 182(3), 226-233 (2002
90. Gibbs S, Spiekstra S, Corsini E, Mcleod J, Reinders J. Dendritic cell migration assay: A potential prediction model for identification of contact allergens. Toxicol. In Vitro 27(3), 1170-1179 (2012
91. Azam P, Peiffer JL, Chamousset D et al. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol. Appl. Pharmacol. 212(1), 14-23 (2006
92. Ashikaga T, Yoshida Y, Hirota M et al. Development of an in vitro skin sensitization test using human cell lines: The human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol. In Vitro 20(5), 767-773 (2006
93. Ade N, Martinozzi-Teissier S, Pallardy M, Rousset F. Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J. Immunotoxicol. 3(4), 189-197 (2006
94. Ashikaga T, Sakaguchi H, Sono S et al. A comparative evaluation of in vitro skin sensitisation tests: The human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern. Lab. Anim. 38(4), 275-284 (2010
95. Sakaguchi H, Ryan C, Ovigne JM, Schroeder KR, Ashikaga T. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol. In Vitro 24(6), 1810-1820 (2010
96. Nukada Y, Ashikaga T, Sakaguchi H et al. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT). Contact Dermatitis 65(6), 343-353 (2011
97. Nukada Y, Ito Y, Miyazawa M, Sakaguchi H, Nishiyama N. The relationship between CD86 and CD54 protein expression and cytotoxicity following stimulation with contact allergen in THP-1 cells. J. Toxicol. Sci. 36(3), 313-324 (2011
98. Maxwell G, Aeby P, Ashikaga T et al. Skin sensitisation: The Colipa strategy for developing and evaluating non-animal test methods for risk assessment. ALTEX 28(1), 50-55 (2011
99. Cluzel-Tailhardat M, Bonnet-Duquennoy M, Abaibou H et al. Which house-keeping genes for dendritic cell transcriptomic studies? Eur. J. Dermatol. 17(5), 457-459 (2007
100. Szameit S, Vierlinger K, Farmer L, Tuschl H, Noehammer C. Gene expression studies in cultured dendritic cells: New indicators for the discrimination of skin sensitizers and irritants in vitro. Clin. Exp. Allergy 39(6), 856-868 (2009
101. Lambrechts N, Nelissen I, Van Tendeloo V et al. Functionality and specificity of gene markers for skin sensitization in dendritic cells. Toxicol. Lett. 203(2), 106-110 (2011
102. Johansson H, Albrekt AS, Borrebaeck CA, Lindstedt M. The GARD assay for assessment of chemical skin sensitizers. Toxicol. In Vitro 27(3), 1163-1169 (2012
103. Neves BM, Rosa SC, Martins JD et al. Development of an in vitro dendritic cell-based test for skin sensitizer identification. Chem. Res. Toxicol. 26(3), 368-378 (2013
104. Dietz L, Kinzebach S, Ohnesorge S et al. Proteomic allergen-peptide/ protein interaction assay for the identification of human skin sensitizers. Toxicol. In Vitro 27(3), 1157-1162 (2012
105. Ouwehand K, Santegoets SJ, Bruynzeel DP, Scheper RJ, De Gruijl TD, Gibbs S. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur. J. Immunol. 38(11), 3050-3059 (2008
106. Ouwehand K, Spiekstra SW, Reinders J, Scheper RJ, De Gruijl TD, Gibbs S. Comparison of a novel CXCL12/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells. Toxicol. In Vitro 24(2), 578-585 (2010
107. Ouwehand K, Spiekstra SW, Waaijman T, Scheper RJ, De Gruijl TD, Gibbs S. Technical advance: Langerhans cells derived from a human cell line in a full-thickness skin equivalent undergo allergen-induced maturation and migration. J. Leukoc. Biol. 90(5), 1027-1033 (2011
108. Dearman RJ, Cumberbatch M, Portsmouth C, Maxwell G, Basketter DA, Kimber I. Synergistic effects of chemical insult and toll-like receptor ligands on dendritic cell activation. Toxicol. In Vitro 22(8), 1927-1934 (2008
109. Cao YP, Ma PC, Liu WD et al. Evaluation of the skin sensitization potential of chemicals in THP-1/keratinocyte co-cultures. Immunopharmacol. Immunotoxicol. 34(2), 196-204 (2012
110. Hennen J, Aeby P, Goebel C et al. Cross talk between keratinocytes and dendritic cells: Impact on the prediction of sensitization. Toxicol. Sci. 123(2), 501-510 (2011
111. Kimber I, Maxwell G, Gilmour N, Dearman RJ, Friedmann PS, Martin SF. Allergic contact dermatitis: A commentary on the relationship between T lymphocytes and skin sensitising potency. Toxicology 291(1-3), 18-24 (2012
112. Martin SF, Esser PR, Schmucker S et al. T-cell recognition of chemicals, protein allergens and drugs: Towards the development of in vitro assays. Cell Mol. Life Sci. 67(24), 4171-4184 (2010
113. Hauser C, Katz SI. Generation and characterization of T-helper cells by primary in vitro sensitization using Langerhans cells. Immunol. Rev. 117, 67-84 (1990
114. Moulon C, Peguet-Navarro J, Courtellemont P, Redziniak G, Schmitt D. Human in vitro T cell sensitization using haptenmodified epidermal Langerhans cells. Adv. Exp. Med. Biol. 329, 209-212 (1993
115. Rougier N, Redziniak G, Mougin D, Schmitt D, Vincent C. In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells. Toxicology 145(1), 73-82 (2000
116. Krasteva M, Peguet-Navarro J, Moulon C, Courtellemont P, Redziniak G, Schmitt D. In vitro primary sensitization of haptenspecific T cells by cultured human epidermal Langerhans cells -A screening predictive assay for contact sensitizers. Clin. Exp. Allergy 26(5), 563-570 (1996
117. Rustemeyer T, De Ligter S, Von Blomberg BM, Frosch PJ, Scheper RJ. Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clin. Exp. Immunol. 117(2), 209-216 (1999
118. Vocanson M, Rozieres A, Hennino A et al. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. J. Allergy Clin. Immunol. 126(2), 280-289 (2010
119. Vocanson M, Hennino A, Cluzel-Tailhardat M et al. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J. Invest. Dermatol. 126(4), 815-820 (2006
120. Vocanson M, Cluzel-Tailhardat M, Poyet G et al. Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens. J. Invest. Dermatol. 128(8), 2119-2122 (2008
121. Richter A, Schmucker SS, Esser PR et al. Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC -IFN-gamma and TNF-alpha readout. Toxicol. In Vitro 27(3), 1180-1185 (2012
122. Dietz L, Esser PR, Schmucker SS et al. Tracking human contact allergens: From mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. Toxicol. Sci. 117(2), 336-347 (2010
123. Faulkner L, Martinsson K, Santoyo-Castelazo A et al. The development of in vitro culture methods to characterize primary T-cell responses to drugs. Toxicol. Sci. 127(1), 150-158 (2012
124. Balato A. The laboratory role in the assessment of sensitization and irritation potential of cosmetics. Annali. Italiani Dermatol. Allergol. Clin. Sperimentale 66, 9-23 (2012